Home > Insider Trading > Filing (0001209191-22-059733)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1659323	Iterum Therapeutics Plc	ITRM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792314	Sailaja Puttagunta	C/O Iterum Therapeutics Plc Fitzwilliam Court, Fl. 1, Leeson Close Dublin 2 L2	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2022-12-01	8,334	$0.00	8,334	No	4	A	Direct
Ordinary Shares	Disposition	2022-12-02	3,365	$1.32	4,969	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Share Units	Disposition	2022-12-01	8,334	$0.00	8,334	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,999			No	4	M	Direct

Footnotes

On August 17, 2022, the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported on this Form 4 have been adjusted to reflect the Reverse Share Split
Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022.